![]() Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
| ![]() Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. | ![]() Talaris Therapeutics Talaris Therapeutics is a cell therapy company developing an method of allogeneic hematopoietic stem cell transplantation. | ||
Founding Date | Founding Date 2015 | Founding Date 2007 | Founding Date 2002 | Founding Date 2019 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Basel, CH HQ Roma, IT | Locations Newton, US HQ Needham, US | Locations Wellesley, US HQ Houston, US Louisville, US Louisville, US Louisville, US | Locations Waltham, US HQ |
Employees | Employees 445% increase | Employees 592% decrease | Employees 82 | Employees 69 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 18.4 m | Valuation ($) 119.6 m | Valuation ($) N/A |
Employee Rating | Employee Rating N/A | Employee Rating 4.1 | Employee Rating 3.8 | Employee Rating 5 |
Financial | ||||
Net income | Net income N/A | Net income ($52.5m) (FY, 2021) | Net income ($73.9m) (FY, 2022) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 49m (about 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 60m (over 3 years ago) |
Total funding raised | Total funding raised $ 62.6m | Total funding raised $ 100m | Total funding raised $ 215m | Total funding raised $ 60m |
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View companyTalaris Therapeutics is a cell therapy company developing an method of allogeneic hematopoietic stem cell transplantation.
View company